A2B Australia Limited:企業の戦略・SWOT・財務分析

◆英語タイトル:A2B Australia Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3428
◆発行会社(調査会社):MarketLine
◆発行日:2019年11月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Transport and Logistics
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

A2B Australia Limited – Strategy, SWOT and Corporate Finance Report
Summary

A2B Australia Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

A2B Australia Limited (A2B Australia), formerly Cabcharge Australia Limited (Cabcharge) offers taxi payments services. The company offers technology services, financial services and passenger transportation services. It also develops and manufactures in-taxi equipment. The company offers electronic payment services, taxi operating services, smash repairs, vehicle loan, leasing and insurance services, and training services to taxi operators. The company offers bus and coach operating services. It operates the brands such as FASTCARD, eTICKET, FAREWAYplus and 13cabs. Its payment application in used by individuals and corporate passengers along with banks, retailers and service providers. The company operates in Australia.A2B Australia is headquartered in Sydney, New South Wales, Australia.

Scope

- Detailed information on A2B Australia Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting A2B Australia Limited in the form of a SWOT analysis
- An in-depth view of the business model of A2B Australia Limited including a breakdown and examination of key business segments
- Intelligence on A2B Australia Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about A2B Australia Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of A2B Australia Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess A2B Australia Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on A2B Australia Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
A2B Australia Limited: Company Overview
A2B Australia Limited: Overview and Key Facts
A2B Australia Limited: Overview
A2B Australia Limited: Key Facts
A2B Australia Limited: Key Employees
A2B Australia Limited: Key Employee Biographies
A2B Australia Limited: Major Products and Services
A2B Australia Limited: Company History
A2B Australia Limited: Management Statement
A2B Australia Limited: Locations and Subsidiaries
A2B Australia Limited: Key Competitors
A2B Australia Limited: Company Analysis
A2B Australia Limited: Business Description
A2B Australia Limited: SWOT Analysis
A2B Australia Limited: SWOT Overview
A2B Australia Limited: Strengths
A2B Australia Limited: Weaknesses
A2B Australia Limited: Opportunities
A2B Australia Limited: Threats
A2B Australia Limited: Corporate Financial Deals Activity
A2B Australia Limited: Financial Deals Overview
A2B Australia Limited: Targets and Partners
A2B Australia Limited: Top Deals 2015 – 2019YTD*
A2B Australia Limited: Advisors
A2B Australia Limited: Top Legal Advisors
A2B Australia Limited: Top Financial Advisors
A2B Australia Limited: Mergers and Acquisitions
A2B Australia Limited: Divestments
A2B Australia Limited: Recent Developments
A2B Australia Limited: News and Events Summary
A2B Australia Limited: Corporate Governance
A2B Australia Limited: Financial Performance
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: A2B Australia Limited: Key Facts
Table 2: A2B Australia Limited: Key Employees
Table 3: A2B Australia Limited: Company History
Table 4: A2B Australia Limited: Locations and Subsidiaries
Table 5: A2B Australia Limited: Key Competitors
Table 6: A2B Australia Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 7: A2B Australia Limited: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: A2B Australia Limited: M&A Average Deal Size - Value (US$m)
Table 9: A2B Australia Limited: Targets and Partners
Table 10: A2B Australia Limited: Top Deals 2015 - 2019YTD*
Table 11: A2B Australia Limited: Legal Advisor Ranking by Value (US$m)
Table 12: A2B Australia Limited: Financial Advisor Ranking by Value (US$m)
Table 13: A2B Australia Limited: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: A2B Australia Limited: M&A Activity by Geography (2015 - YTD*2019)
Table 15: A2B Australia Limited: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 16: A2B Australia Limited: Divestments by Geography (2015 - YTD*2019)
Table 17: A2B Australia Limited: News and Events Summary
Table 18: A2B Australia Limited: Corporate Governance
Table 19: A2B Australia Limited: Financial Performance

★海外企業調査レポート[A2B Australia Limited:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DURECT Corp (DRRX):医療機器:M&Aディール及び事業提携情報
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …
  • Poxel SA (POXEL):企業の財務・戦略的SWOT分析
    Summary Poxel SA (Poxel) is a biopharmaceutical company that focuses to develop drugs for metabolic diseases. The company’s pipeline product portfolio includes Imeglimin, which is developed to target mitochondrial dysfunction, for the treatment of type 2 diabetes; PXL065, a mitochondrial pyruvate ca …
  • Hite Jinro Co., Ltd:企業の戦略・SWOT・財務情報
    Hite Jinro Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Hite Jinro Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Coats Group plc:企業のM&A・事業提携・投資動向
    Coats Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coats Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • EnCana Corporation:企業の戦略・SWOT・財務情報
    EnCana Corporation - Strategy, SWOT and Corporate Finance Report Summary EnCana Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Southwestern Energy Co (SWN):企業の財務・戦略的SWOT分析
    Southwestern Energy Co (SWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Biogen Inc (BIIB):企業の財務・戦略的SWOT分析
    Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • AnaptysBio Inc:企業のM&A・事業提携・投資動向
    AnaptysBio Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AnaptysBio Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • EnCana Corporation (ECA):石油・ガス:M&Aディール及び事業提携情報
    Summary EnCana Corp (EnCana) is an oil and gas producer. The company explores, develops, produces and markets natural gas, oil and natural gas liquids (NGLs). Its major resource plays include Montney, Duvernay, Wheatland Oil play, Deep Panuke, Horn River and other emerging plays in Canada. In the US …
  • Honshu Chemical Industry Co Ltd (4115):企業の財務・戦略的SWOT分析
    Honshu Chemical Industry Co Ltd (4115) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Velan Inc (VLN):企業の財務・戦略的SWOT分析
    Velan Inc (VLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • SunVic Chemical Holdings Ltd (A7S):企業の財務・戦略的SWOT分析
    SunVic Chemical Holdings Ltd (A7S) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Southern Petrochemical Industries Corp Ltd (SPIC):企業の財務・戦略的SWOT分析
    Summary Southern Petrochemical Industries Corp Ltd (SPIC) is a chemical company that manufactures fertilizers for agriculture. The company offers products such as chemical fertilizer, organic and water soluble fertilizers, plant growth regulators, micro nutrients, and industrial products. Its chemic …
  • Valecha Engineering Ltd:企業の戦略・SWOT・財務分析
    Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Stingray Digital Group Inc.:企業のM&A・事業提携・投資動向
    Stingray Digital Group Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Stingray Digital Group Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • La-Z-Boy Incorporated:企業の戦略・SWOT・財務情報
    La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report Summary La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • CACI International Inc. (CACI):企業の戦略的SWOT分析
    CACI International Inc. (CACI) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Protagen AG-製薬・医療分野:企業M&A・提携分析
    Summary Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The company’s products include multilisa Ssc, multilisa SLE and multilisa RA. It provides products for autoimmune diseases such as rheumatoid arthritis, neuromyeliti …
  • BioXcel Therapeutics Inc (BTAI):製薬・医療:M&Aディール及び事業提携情報
    Summary BioXcel Therapeutics Inc (BioXcel Therapeutics) a subsidiary of BioXcel Corp is a clinical stage biopharmaceutical company focused on novel artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology. Its pipeline product portfolio includes BXCL501, an ad …
  • Mizuno Corporation (8022):企業の財務・戦略的SWOT分析
    Mizuno Corporation (8022) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆